Avenue Therapeutics Inc (ATXI)
3.815
+0.18
(+5.10%)
USD |
NASDAQ |
May 17, 16:00
3.88
+0.06
(+1.70%)
After-Hours: 20:00
Avenue Therapeutics Cash from Financing (Quarterly): 4.531M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.531M |
| December 31, 2023 | 3.946M |
| September 30, 2023 | 0.479M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 3.101M |
| December 31, 2022 | 10.66M |
| September 30, 2022 | -0.119M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 4.381M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.012M |
| March 31, 2019 | 32.34M |
| December 31, 2018 | -0.895M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -6.754M |
| June 30, 2017 | 35.30M |
| March 31, 2017 | -0.163M |
| December 31, 2016 | 0.24M |
| September 30, 2016 | 0.441M |
| June 30, 2016 | 0.259M |
| March 31, 2016 | 0.875M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.119M
Minimum
Sep 2022
10.66M
Maximum
Dec 2022
1.926M
Average
--
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Fortress Biotech Inc | 27.86M |
| SINTX Technologies Inc | 5.328M |
| Deciphera Pharmaceuticals Inc | 0.522M |
| Flora Growth Corp | 0.704M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.12M |
| Free Cash Flow | -11.00M |
| Free Cash Flow Per Share (Quarterly) | -416.39 |
| Free Cash Flow Yield | -2.10K% |